(Q36944312)

English

A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia

scientific article published on 10 June 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia (English)

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

0 references

mesenchymal stem cell

1 reference

based on heuristic

inferred from title

author name string

Pawan K Gupta

1

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Anoop Chullikana

2

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Rajiv Parakh

3

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Sanjay Desai

4

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Anjan Das

5

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Sanjay Gottipamula

6

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Sagar Krishnamurthy

7

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Naveen Anthony

8

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Arun Pherwani

9

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Anish S Majumdar

10

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

publication date

10 June 2013

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Journal of Translational Medicine

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

11

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

143

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

copyright license

Creative Commons Attribution 2.0 Generic

10 June 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

https://scigraph.springernature.com/pub.10.1186/1479-5876-11-143

0 references

Intra-arterial allogeneic mesenchymal stem cells for critical limb ischemia are safe and efficacious: report of a phase I study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688296

29 September 2017

Cellular therapy with Ixmyelocel-T to treat critical limb ischemia: the randomized, double-blind, placebo-controlled RESTORE-CLI trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688296

29 September 2017

Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688296

29 September 2017

Autologous bone-marrow mononuclear cell implantation reduces long-term major amputation risk in patients with critical limb ischemia: a comparison of atherosclerotic peripheral arterial disease and Buerger disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688296

29 September 2017

A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688296

29 September 2017

Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688296

29 September 2017

Treatment with autologous bone marrow mononuclear cells in patients with critical lower limb ischaemia. A pilot study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688296

29 September 2017

Progenitor cell therapy in patients with critical limb ischemia without surgical options

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688296

29 September 2017

Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688296

29 September 2017

Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688296

29 September 2017

Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688296

29 September 2017

Unblinded pilot study of autologous transplantation of bone marrow mononuclear cells in patients with thromboangiitis obliterans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688296

29 September 2017

Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II-III thromboangiitis obliterans.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688296

29 September 2017

ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society f

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688296

29 September 2017

New molecular pathways in angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688296

29 September 2017

Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688296

29 September 2017

Origin of endothelial progenitors in human postnatal bone marrow

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688296

29 September 2017

Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688296

29 September 2017

Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688296

29 September 2017

Multilineage potential of adult human mesenchymal stem cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688296

29 September 2017

Isolation of putative progenitor endothelial cells for angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688296

29 September 2017

Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688296

29 September 2017

Evidence for circulating bone marrow-derived endothelial cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688296

27 June 2018

The use of stem cells in the treatment of inoperable limb ischemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688296

4 September 2018

Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688296

4 September 2018

Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688296

4 September 2018

Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688296

4 September 2018

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3688296

4 September 2018

Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells

1 reference

https://api.crossref.org/works/10.1186%2F1479-5876-11-143

21 January 2018

Intraarterial Administration of Bone Marrow Mononuclear Cells in Patients With Critical Limb Ischemia

1 reference

https://api.crossref.org/works/10.1186%2F1479-5876-11-143

21 January 2018

Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23758736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stem cell and progenitor cell therapy in peripheral artery disease. A critical appraisal

1 reference

https://pubmed.ncbi.nlm.nih.gov/23758736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beneficial effects of VEGF secreted from stromal cells in supporting endothelial cell functions: therapeutic implications for critical limb ischemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23758736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23758736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model

1 reference

https://pubmed.ncbi.nlm.nih.gov/23758736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex

1 reference

https://pubmed.ncbi.nlm.nih.gov/23758736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neovascularization induced by autologous bone marrow cell implantation in peripheral arterial disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23758736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization

1 reference

https://pubmed.ncbi.nlm.nih.gov/23758736

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1479-5876-11-143

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36944312&oldid=1799561704"